Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408013 | 12540801 | 3 | F | 2014 | 20160818 | 20160708 | 20160823 | EXP | US-JNJFOC-20160626647 | JANSSEN | 0.00 | A | F | Y | 58.97000 | KG | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408013 | 12540801 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | THIRD SHOT (INJECTION) | N | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||
| 125408013 | 12540801 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | FOURTH INJECTION | N | UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||
| 125408013 | 12540801 | 3 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | UNKNOWN | 125261 | SOLUTION FOR INJECTION | ||||||||
| 125408013 | 12540801 | 4 | C | EXCEDRIN | ACETAMINOPHENASPIRINCAFFEINE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125408013 | 12540801 | 5 | C | BETAMETHASONE. | BETAMETHASONE | 1 | Topical | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125408013 | 12540801 | 1 | Psoriasis |
| 125408013 | 12540801 | 2 | Psoriasis |
| 125408013 | 12540801 | 3 | Psoriasis |
| 125408013 | 12540801 | 4 | Migraine |
| 125408013 | 12540801 | 5 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125408013 | 12540801 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125408013 | 12540801 | Abdominal pain upper | |
| 125408013 | 12540801 | Blindness | |
| 125408013 | 12540801 | Diverticulitis | |
| 125408013 | 12540801 | Dizziness | |
| 125408013 | 12540801 | Fatigue | |
| 125408013 | 12540801 | General physical health deterioration | |
| 125408013 | 12540801 | Glucose tolerance impaired | |
| 125408013 | 12540801 | Hypersomnia | |
| 125408013 | 12540801 | Psoriasis | |
| 125408013 | 12540801 | Pyrexia | |
| 125408013 | 12540801 | Sinusitis | |
| 125408013 | 12540801 | Skin discolouration | |
| 125408013 | 12540801 | Tremor | |
| 125408013 | 12540801 | Ulcer | |
| 125408013 | 12540801 | Vomiting | |
| 125408013 | 12540801 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125408013 | 12540801 | 3 | 2014 | 0 |